Sustained-release tablets are suitable for drugs with moderate half-lives (~4-8 hours), ensuring controlled drug release.
Metformin (6 hr) fits this profile, allowing prolonged therapeutic action while reducing dosing frequency.
Drugs with very short or long half-lives are less suited for sustained-release formulations.